Omeros (OMER) Revenue Growth (1y) (2011 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 14.90% |
| Jun 30, 2021 | 113.03% |
| Mar 31, 2021 | -10.52% |
| Dec 31, 2020 | -68.18% |
| Sep 30, 2020 | -12.53% |
| Jun 30, 2020 | -49.43% |
| Mar 31, 2020 | 8.07% |
| Dec 31, 2019 | 51.78% |
| Sep 30, 2019 | 547.92% |
| Jun 30, 2019 | 1,516.50% |
| Mar 31, 2019 | 1,271.47% |
| Dec 31, 2018 | 60.01% |
| Sep 30, 2018 | -78.72% |
| Jun 30, 2018 | -90.35% |
| Mar 31, 2018 | -87.04% |
| Dec 31, 2017 | 6.63% |
| Sep 30, 2017 | 91.85% |
| Jun 30, 2017 | 71.44% |
| Mar 31, 2017 | 65.21% |
| Dec 31, 2016 | 93.33% |
| Sep 30, 2016 | 246.39% |
| Jun 30, 2016 | 213.90% |
| Mar 31, 2016 | 1,812.11% |
| Dec 31, 2015 | 3,608.33% |
| Sep 30, 2015 | 1,422.90% |
| Jun 30, 2015 | 6,982.22% |
| Mar 31, 2015 | 288.00% |
| Dec 31, 2014 | 6.51% |
| Sep 30, 2014 | 9.18% |
| Jun 30, 2014 | -67.86% |
| Mar 31, 2014 | -90.87% |
| Dec 31, 2013 | -89.32% |
| Sep 30, 2013 | -86.17% |
| Jun 30, 2013 | -90.83% |
| Mar 31, 2013 | -26.80% |
| Dec 31, 2012 | 38.50% |
| Sep 30, 2012 | 43.57% |
| Jun 30, 2012 | 32.12% |
| Mar 31, 2012 | 20.74% |
| Dec 31, 2011 | 17.11% |
| Sep 30, 2011 | 288.58% |
| Jun 30, 2011 | 132.39% |